SemaglutideOverview: Semaglutide is a GLP-1 analog with therapeutic applications in type 2 diabetes and obesity. It enhances insulin secretion and reduces appetite, leading to improved glycemic control and weight loss.Product Specification:Purity: >99% (HPLC verified)Formulation: Lyophilized powder for reconstitutionMolecular Formula: C187H291N45O59Molecular Weight: 41144 g/molCAS Number: 910463-68-2PubChem CID: 56843331Source: PubChemProduct Features:GLP-1 analog simulating human incretin activityEnhances insulin secretion and beta cell functionDelays gastric emptying, reducing appetiteSupports weight management in obesityExhibits cardioprotective and neuroprotective potentialResearch Applications:Diabetes Management: Manages blood sugar levels and pancreatic function.Obesity Treatment: Aids in significant weight loss through appetite suppression.Cardiovascular Health: May improve heart function and reduce heart failure risks.Neurological Impact: Potential to protect against neurodegenerative diseases.Conclusion: Sema is a promising agent in metabolic research, particularly for diabetes and obesity treatments. It offers a multifaceted approach to disease management, impacting several health domains.Important Notice: This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabeled as a drug, food or cosmetic.COA Batch 9104-0124-5 (5mg)Batch 9104-0124-5COA Batch 9104-0124-10 (10mg)Batch 9104-0124-10